French pharmacovigilance survey of casirivimab - imdevimab monoclonal antibodies in coronavirus disease (COVID-19)

INTRODUCTION: Casirivimab and imdevimab (Ronapreve®) are two recombinant human monoclonal antibodies (mAbs) that bind to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein, preventing the virus from entering cells. In March 2021, this drug was granted emergency use author...

Descripción completa

Detalles Bibliográficos
Autores principales: de Canecaude, Claire, Montastruc, François, Bergeron, Sandrine, Sanchez-Pena, Paola, Grandvuillemin, Aurélie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2023
Materias:
Pharmacovigilance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943551/
https://www.ncbi.nlm.nih.gov/pubmed/36918316
http://dx.doi.org/10.1016/j.therap.2023.02.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943551/
https://www.ncbi.nlm.nih.gov/pubmed/36918316
http://dx.doi.org/10.1016/j.therap.2023.02.004

Ejemplares similares